Agilent Technologies Inc. (A) carries a Roarable Rating of C+ (Hold) with 66/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
Agilent Technologies Inc. (A) slipped -0.18% to $181.15 as options desks priced 57% call premium vs. 43% put protection around the $178 max-pain magnet. Solid 52% profit margin (15% return on capital), mixed timing at 39x P/E—hold if owned, no rush to chase.
Profiles Roche Diagnostics, Thermo Fisher Scientific, Merck KGaA, Agilent Technologies and Silence Therapeutics, covering their RNAi technology market activities.Dublin, Oct. 30, 2026 (GLOBE NEWSWIRE) -- "Ribonucleic Aci
Players: Thermo Fisher, Labcorp, Quest Diagnostics, Eurofins, Agilent. Profiles cover fetal aneuploidy tests, technologies, applications and end users.Dublin, Oct. 30, 2026 (GLOBE NEWSWIRE) -- "Fetal Aneuploidy Confirmat
Agilent Technologies (A) has partnered with the University of Chicago to establish a new Center of Excellence for Energy Materials Research, placing its analytical instruments at the center of next generation battery and
SANTA CLARA, Calif., October 29, 2026--Agilent Technologies Inc. (NYSE: A) will release financial results for the fourth quarter of fiscal year 2026 after the stock market closes on Monday, Nov. 23. The company will host
In October 2026, Agilent Technologies and the University of Chicago announced a Center of Excellence for Energy Materials Research, using Agilent mass spectrometry and atomic spectroscopy tools to study next generation b
Boost ROI by targeting services, computer vision, drug discovery, diagnostic labs and Asia-Pacific, supported by cloud integration and strategic partnershipsDublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "AI in Pathology Mark
Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "Long Oligo Pool Synthesis for Capture Global Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global long oligo pool synthesis for capture market is
Profiles Roche, Thermo Fisher, Eurofins, Agilent and Illumina, covering bead-linked transposase kits for streamlined DNA/RNA sequencing-library preparationDublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "Bead-Linked Transposas
Align Technology's Q3 earnings and revenues beat estimates on higher aligner shipments, but a lowered 2026 sales outlook weighs on shares.
Boost ROI by targeting pharma, portable and AI-enabled spectroscopy, rapid testing, regulatory compliance, and Asia-Pacific expansion.Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "Molecular Spectroscopy - Global Strategic B
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +6.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on A today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for A. Explore sector supply chains on /butterfly.
Why A Stock slipped -0.18% Today — RQD Quant Desk Flash. Solid 52% profit margin (15% return on capital), mixed timing at 39x P/E—hold if owned, no rush to chase.